Cargando…

Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism

Deficiency in the serine protease inhibitor, alpha-1 antitrypsin (AAT), is known to cause emphysema and liver disease. Other manifestations, including airway disease or skin disorders, have also been described. A 44-year-old woman presented to our emergency department with dyspnea and respiratory in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milger, Katrin, Holdt, Lesca Miriam, Teupser, Daniel, Huber, Rudolf Maria, Behr, Jürgen, Kneidinger, Nikolaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428364/ https://www.ncbi.nlm.nih.gov/pubmed/26005342 http://dx.doi.org/10.2147/COPD.S80173

Ejemplares similares

Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency
por: Matamala, Nerea, et al.
Publicado: (2015)

SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency
por: Connolly, Brendan, et al.
Publicado: (2018)

Variants of SERPINA1 and the increasing complexity of testing for alpha-1 antitrypsin deficiency
por: Foil, Kimberly E.
Publicado: (2021)

Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression
por: Karadagi, Ahmad, et al.
Publicado: (2017)

A Novel SERPINA1 Mutation Causing Serum Alpha(1)-Antitrypsin Deficiency
por: Saunders, Darren N., et al.
Publicado: (2012)

Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum
por: Seixas, Susana, et al.
Publicado: (2021)

SERPINA1 and More? A Putative Genetic Contributor to Pulmonary Dysfunction in Alpha-1 Antitrypsin Deficiency
por: Jezela-Stanek, Aleksandra, et al.
Publicado: (2023)

Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasis
por: Carreto, Luis, et al.
Publicado: (2020)

Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease
por: Carvalho, Magda Oliveira Seixas, et al.
Publicado: (2017)

Clinical Significance of SERPINA1 Gene and Its Encoded Alpha1-Antitrypsin Protein in NSCLC
por: Ercetin, Evrim, et al.
Publicado: (2019)

Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
por: Stockley, Robert A., et al.
Publicado: (2023)

Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency
por: Kueppers, Friedrich, et al.
Publicado: (2019)

Causal and Synthetic Associations of Variants in the SERPINA Gene Cluster with Alpha1-antitrypsin Serum Levels
por: Thun, Gian Andri, et al.
Publicado: (2013)

Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?
por: Mümmler, Carlo, et al.
Publicado: (2020)

Daily Chronic Intermittent Hypobaric Hypoxia Does Not Induce Chronic Increase in Pulmonary Arterial Pressure Assessed by Echocardiography
por: Götschke, Jeremias, et al.
Publicado: (2018)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
por: Buck, Emanuel, et al.
Publicado: (2022)

Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: SERPINA1 MZ or MS Genotype Carriage Decreases the Risk
por: Rabekova, Zuzana, et al.
Publicado: (2021)

Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities
por: Barnikel, Michaela, et al.
Publicado: (2022)

A combined in silico and in vitro study on mouse Serpina1a antitrypsin-deficiency mutants
por: Eggenschwiler, Reto, et al.
Publicado: (2019)

Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency
por: Cummings, Erin E., et al.
Publicado: (2015)

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
por: Veith, Martina, et al.
Publicado: (2020)

Population genetic testing and SERPINA1 sequencing identifies unidentified alpha-1 antitrypsin deficiency alleles and gene-environment interaction with hepatitis C infection
por: Schuler, Bryce A., et al.
Publicado: (2023)

Molecular characterization of PI(*)S(hangzhou), a SERPINA1 allele from continental China encoding a defective alpha-1-antitrypsin
por: Hernández-Pérez, José M., et al.
Publicado: (2022)

An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey
por: Tural Onur, Seda, et al.
Publicado: (2023)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatment
por: Mertsch, Pontus, et al.
Publicado: (2022)

From genotype to phenotype in human atherosclerosis - recent findings
por: Holdt, Lesca M., et al.
Publicado: (2013)

Long Noncoding RNA ANRIL: Lnc-ing Genetic Variation at the Chromosome 9p21 Locus to Molecular Mechanisms of Atherosclerosis
por: Holdt, Lesca M., et al.
Publicado: (2018)

Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study
por: Kok, Karin F, et al.
Publicado: (2010)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

Autophagy master regulator TFEB induces clearance of toxic SERPINA1/α-1-antitrypsin polymers
por: Pastore, Nunzia, et al.
Publicado: (2013)

Domestic Parasitic Infections in Patients with Asthma and Eosinophilia in Germany – Three Cases with Learnings in the Era of Anti- IL5 Treatments
por: Barnikel, Michaela, et al.
Publicado: (2023)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
por: Fähndrich, Sebastian, et al.
Publicado: (2017)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
por: Shaik, Noor Ahmad, et al.
Publicado: (2022)

alpha1-Antitrypsin deficiency and hepatocellular cancer.
por: Kew, M. C., et al.
Publicado: (1978)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
por: Carroll, Tomás P, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s795qj15qlt19b3rmukjjsrkjm